Literature DB >> 10206241

Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia.

R G Ross1, A Olincy, J G Harris, A Radant, M Hawkins, L E Adler, R Freedman.   

Abstract

Childhood-onset schizophrenia is proposed to be associated with increased genetic loading compared with adult-onset schizophrenia because of its earlier age of onset and generally greater severity of symptoms. Diminished suppression of P50 auditory evoked responses to repeated stimuli and elevated anticipatory saccades during smooth pursuit eye movements are markers of genetic risk that are found in members of families with schizophrenia even in the absence of the full clinical disorder and appear to be transmitted in a single gene autosomal dominant fashion. Adult-onset schizophrenia is generally associated with one parent who demonstrates abnormal P50 sensory gating and elevated anticipatory saccades and one parent who is normal on the physiologic measures (i.e., unilineal inheritance). This study investigates whether childhood-onset schizophrenia is similarly unilineal or is associated with the inheritance of genetic risk factors from both parents (i.e., bilineal inheritance). Ten childhood-onset schizophrenic probands and their parents were studied. Their P50 sensory gating and anticipatory saccades were compared with adult-onset schizophrenic probands and their parents. Bilineality, measured as physiological impairment in both parents, occurred more frequently in childhood-onset probands than in adult-onset probands for both P50 sensory gating deficits (60% versus 13%) and elevated anticipatory saccades (60 versus 0%). Additionally, childhood-onset schizophrenic probands performed more poorly than adult-onset probands on the anticipatory saccade measure. This physiological evidence suggests that childhood-onset schizophrenia may be associated with increased genetic loading because of contributions of genetic risk from both parents.

Entities:  

Mesh:

Year:  1999        PMID: 10206241

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

Review 1.  Neuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings.

Authors:  Anna E Ordóñez; Zoe I Luscher; Nitin Gogtay
Journal:  Schizophr Res       Date:  2015-03-26       Impact factor: 4.939

2.  Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder.

Authors:  Cecilie Koldbæk Lemvigh; Jens Richardt Møllegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Birte Yding Glenthøj; Jacob Rydkjær; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2019-10-24       Impact factor: 7.853

3.  Neuropsychological functioning in childhood-onset psychosis and attention-deficit/hyperactivity disorder.

Authors:  Kimberly Brodsky; Erik G Willcutt; Deana B Davalos; Randal G Ross
Journal:  J Child Psychol Psychiatry       Date:  2014-01-24       Impact factor: 8.982

Review 4.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

Review 5.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

6.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 7.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

8.  Psychiatric disorders in clinical genetics II: Individualizing recurrence risks.

Authors:  Jehannine C Austin; Christina G S Palmer; Beth Rosen-Sheidley; Patricia McCarthy Veach; Elizabeth Gettig; Holly L Peay
Journal:  J Genet Couns       Date:  2007-12-11       Impact factor: 2.537

Review 9.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

10.  Use of the ADOS and ADI-R in children with psychosis: importance of clinical judgment.

Authors:  Judith A Reaven; Susan L Hepburn; Randal G Ross
Journal:  Clin Child Psychol Psychiatry       Date:  2008-01       Impact factor: 2.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.